Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study.
Peyracchia M, De Lio G, Montrucchio C, Omedè P, d'Ettore G, Calcagno A, Vullo V, Cerrato E, Pennacchi M, Sardella G, Manga P, GrossoMarra W, Vullo F, Fedele F, Biondi-Zoccai G, Moretti C, Vachiat A, Bonora S, Rinaldi M, Mancone M, D'Ascenzo F. Peyracchia M, et al. Among authors: calcagno a. Atherosclerosis. 2018 Jul;274:218-226. doi: 10.1016/j.atherosclerosis.2018.05.001. Epub 2018 May 5. Atherosclerosis. 2018. PMID: 29803160
Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide.
González de Requena D, Calcagno A, Bonora S, Ladetto L, D'Avolio A, Sciandra M, Siccardi M, Bargiacchi O, Sinicco A, Di Perri G. González de Requena D, et al. Among authors: calcagno a. AIDS. 2006 Oct 3;20(15):1977-9. doi: 10.1097/01.aids.0000247121.19951.fa. AIDS. 2006. PMID: 16988521
Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimens.
de Requena DG, Bonora S, Calcagno A, D'Avolio A, Siccardi M, Fontana S, Milia MG, Sciandra M, Garazzino S, Di Garbo A, Baietto L, Trentini L, Di Perri G. de Requena DG, et al. Among authors: calcagno a. Antimicrob Agents Chemother. 2008 Mar;52(3):1066-71. doi: 10.1128/AAC.01063-07. Epub 2007 Dec 26. Antimicrob Agents Chemother. 2008. PMID: 18160524 Free PMC article.
[HIV infection: treatment of naive patients].
Bonora S, Calcagno A, Di Perri G. Bonora S, et al. Among authors: calcagno a. Infez Med. 2009 Jun;17(2):69-81. Infez Med. 2009. PMID: 19602919 Free article. Review. Italian.
Raltegravir: is a 400 mg once-daily dose enough?
Lanzafame M, Hill A, Lattuada E, Calcagno A, Bonora S. Lanzafame M, et al. Among authors: calcagno a. J Antimicrob Chemother. 2010 Mar;65(3):595-7. doi: 10.1093/jac/dkp488. Epub 2010 Jan 12. J Antimicrob Chemother. 2010. PMID: 20071368 No abstract available.
Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study.
Bonora S, Calcagno A, Cometto C, Fontana S, Aguilar D, D'Avolio A, Gonzalez de Requena D, Maiello A, Dal Conte I, Lucchini A, Di Perri G. Bonora S, et al. Among authors: calcagno a. Infection. 2012 Feb;40(1):69-75. doi: 10.1007/s15010-011-0223-4. Epub 2011 Dec 2. Infection. 2012. PMID: 22135137 Clinical Trial.
410 results